ALPS Medical Breakthroughs ETF (SBIO) Declines 0.55% for Mar 14

March 14, 2018 - By Maria Brooks

Mar 14 is a negative day so far for ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) as the ETF is active during the day after losing 0.55% to hit $36.28 per share. The exchange traded fund has 168.36 million net assets and 3.31% volatility this month.

Over the course of the day 16,126 shares traded hands, as compared to an average volume of 56,240 over the last 30 days for ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO).

The ETF is -21.73% of its 52-Week High and 34.25% of its low, and is currently having ATR of 0.92. This year’s performance is -18.92% while this quarter’s performance is 0.47%.

The ETF’s YTD performance is 0%, the 1 year is 0% and the 3 year is 0%.

More notable recent ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) news were published by: which released: “ALPS Medical Breakthroughs ETF SBIO (US: NYSE Arca)” on March 01, 2015, also with their article: “Best ETFs for 2018: Break Through With the ALPS Medical Breakthroughs ETF” published on January 10, 2018, published: “ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF” on January 15, 2015. More interesting news about ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) were released by: and their article: “SBIO: A Safe Play In Biotechnology?” published on June 10, 2015 as well as‘s news article titled: “A New Biotech ETF Targets Companies In Late Stage Clinical Trials” with publication date: January 16, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.